These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32191634)

  • 21. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells.
    Berges C; Chatterjee M; Topp MS; Einsele H
    Immunol Res; 2016 Jun; 64(3):687-98. PubMed ID: 26724940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
    Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
    Luo X; Xu L; Li Y; Tan H
    Cell Biol Toxicol; 2017 Apr; 33(2):169-181. PubMed ID: 27770236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-Dose 5-Aza and DZnep Alleviate Acute Graft-
    Wang QY; Liu HH; Dong YJ; Liang ZY; Yin Y; Liu W; Wang QY; Wang Q; Sun YH; Xu WL; Han N; Li Y; Ren HY
    Front Immunol; 2022; 13():780708. PubMed ID: 35281001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.
    Webb LM; Amici SA; Jablonski KA; Savardekar H; Panfil AR; Li L; Zhou W; Peine K; Karkhanis V; Bachelder EM; Ainslie KM; Green PL; Li C; Baiocchi RA; Guerau-de-Arellano M
    J Immunol; 2017 Feb; 198(4):1439-1451. PubMed ID: 28087667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation.
    Jordan WJ; Brookes PA; Szydlo RM; Goldman JM; Lechler RI; Ritter MA
    Blood; 2004 Jan; 103(2):717-24. PubMed ID: 14512310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
    Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
    Front Immunol; 2018; 9():2724. PubMed ID: 30534126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Fujimori Y; Takatsuka H; Takemoto Y; Hara H; Okamura H; Nakanishi K; Kakishita E
    Br J Haematol; 2000 Jun; 109(3):652-7. PubMed ID: 10886219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation.
    Lee CW; Wohlan K; Dallmann I; Förster R; Ganser A; Krueger A; Scherr M; Eder M; Koenecke C
    J Immunol; 2016 May; 196(9):3927-34. PubMed ID: 27009493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventive and Therapeutic Effects of a Novel JAK Inhibitor SHR0302 in Acute Graft-Versus-Host Disease.
    Sun X; He Q; Yang J; Wang A; Zhang F; Qiu H; Zhou K; Wang P; Ding X; Yuan X; Li H; Zhang Y; Song X
    Cell Transplant; 2021; 30():9636897211033778. PubMed ID: 34269100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between CD4(+)CD25(+) regulatory T cells, IL-2, TGF-beta and acute graft-versus host disease after allogeneic hematopoietic stem cell transplantation].
    Niu YY; Ma LM; Zhou Y; Ren RR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):735-9. PubMed ID: 20561440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease.
    Wen Q; Xu ZL; Wang Y; Lv M; Song Y; Lyv ZS; Xing T; Xu LP; Zhang XH; Huang XJ; Kong Y
    Sci China Life Sci; 2023 Mar; 66(3):528-544. PubMed ID: 36166182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
    Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
    Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
    Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting PRMT1 prevents acute and chronic graft-versus-host disease.
    Zhao X; Sun Y; Xu Z; Cai L; Hu Y; Wang H
    Mol Ther; 2023 Nov; 31(11):3259-3276. PubMed ID: 37735873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.
    Oikawa T; Kamimura Y; Akiba H; Yagita H; Okumura K; Takahashi H; Zeniya M; Tajiri H; Azuma M
    J Immunol; 2006 Oct; 177(7):4281-7. PubMed ID: 16982862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.